-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/shah_grant.pdf
September 01, 2013 - Optimizing the Treatment of Diabetes Patients
Optimizing Prevention and Healthcare Management … for the Complex Patient – Pioneer R21 Grants
Optimizing the Treatment of Diabetes Patients
Principal … Therefore, it is
important to identify optimal treatments for these highly complex
patients so that … Increase clinical health
research
Optimizing the Treatment of Diabetes Patients (Continued) … Optimizing the start time of statin therapy for patients
with diabetes.
-
effectivehealthcare.ahrq.gov/products/diabetes-treatment
January 24, 2012 - Treatment Intensification in Type 2 Diabetes Mellitus
Timeline
January 24, 2012
Topic … Initiated
January 24, 2012
Abstract
Archived
Treatment Intensification … in Type 2 Diabetes Mellitus
-
effectivehealthcare.ahrq.gov/products/diabetes-treatment/abstract
January 24, 2012 - Treatment Intensification in Type 2 Diabetes Mellitus
Abstract Archived January 24, 2012 … Topic Abstract
Background: Many patients with type 2 diabetes mellitus (DM) may have other major … Patients often have their DM therapies intensified to reach the recommended hemoglobin A1C (HbA1C) target … ; and, 2) therapy intensified during the first year with insulin. … Three exposures will be examined:
therapy intensified with an additional oral agent
therapy intensified
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - Many patients with T2DM fail to meet treatment goals and require additional
therapy with one of two … New treatments in development for all types of diabetes focus on several aspects of prevention to
delay … treatment compliance
Experts agreed that while any new therapy for the treatment of diabetes would … of T2DM
Intervention
SGLT2 inhibitors for treatment of T2DM
While many current treatments help … A paradigm shift in diabetes therapy--
dapagliflozin and other SGLT2 inhibitors.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - Many patients with T2DM fail to meet treatment goals and require additional
therapy with one of two … New treatments in development for all types of diabetes focus on several aspects of prevention to
delay … treatment compliance
Experts agreed that while any new therapy for the treatment of diabetes would … of T2DM
Intervention
SGLT2 inhibitors for treatment of T2DM
While many current treatments help … A paradigm shift in diabetes therapy--
dapagliflozin and other SGLT2 inhibitors.
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
January 01, 2012 - Many patients with T2DM do not meet treatment goals and require additional therapy
with one of two … New treatments in development for all types of diabetes focus on delaying onset of the disease
in at-risk … One expert with a clinical perspective
also noted that initiation of treatment with this therapy might … Both treatments
were generally well tolerated. … Treatment Adherence
Diabetes Mellitus Interventions
Artificial Pancreas for Treatment of Diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - ) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes
Mellitus Requiring Insulin 5
Fluocinolone … New treatments in development for all types of diabetes focus on delaying disease onset in at-
risk … of Type 2 Diabetes Mellitus
Key Facts: Two therapies for treating T2DM, one in development and … of Type 2 Diabetes Mellitus
Two therapies for treating T2DM, one in development and one recently approved … of Diabetes
Buccal Insulin (Oral-Lyn) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - ) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes
Mellitus Requiring Insulin 5
Fluocinolone … New treatments in development for all types of diabetes focus on delaying disease onset in at-
risk … of Type 2 Diabetes Mellitus
Key Facts: Two therapies for treating T2DM, one in development and … of Type 2 Diabetes Mellitus
Two therapies for treating T2DM, one in development and one recently approved … of Diabetes
Buccal Insulin (Oral-Lyn) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - New treatments in development for diabetes focus on delaying disease onset in at-risk patients
and … of Type 2 Diabetes Mellitus
Key Facts: Two therapies for treating T2DM, one in development and … therapies. … Other treatment options, such as anti-VEGF therapies are available for treating DME, and
according … Intarcia Therapeutics. A study to evaluate ITCA
650 for the treatment of type 2 diabetes.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - New treatments in development for diabetes focus on delaying disease onset in at-risk patients
and … of Type 2 Diabetes Mellitus
Key Facts: Two therapies for treating T2DM, one in development and one … These studies evaluated the safety and efficacy of EQW compared with other diabetes
therapies. … ., anti-VEGF therapies). … Intarcia Therapeutics. A study to evaluate ITCA
650 for the treatment of type 2 diabetes.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - therapeutic effects and better glycemic control. … The mode of
delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is
controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new
intervention just another treatment option … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - In
a May 2015 review published in Diabetes Technology & Therapeutics of almost 21,000
patients who … 2
diabetes mellitus (T2DM) do not meet treatment goals and require additional therapy with one of … medications, behavioral and lifestyle
therapies, glucose monitors, insulin pumps, and treatment protocols … medications, behavioral and lifestyle therapies, glucose
monitors, insulin pumps, and treatment protocols … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - of Type 2 Diabetes
Key Facts: ITCA 650 (Intarcia Therapeutics, Inc., Hayward, CA), is extended-release … The mode of
delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is
controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new
intervention just another treatment option … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - with type 2
diabetes mellitus (T2DM) do not meet treatment goals and require additional therapy with … medications, behavioral and lifestyle
therapies, glucose monitors, insulin pumps, and treatment protocols … medications, behavioral and lifestyle therapies, glucose
monitors, insulin pumps, and treatment protocols … with diabetes to improve compliance with recommended therapy and success at
attaining treatment goals … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - Table A: Inclusion/Exclusion Criteria
KQ1a(Pharmacologic treatments) KQ2a(Pharmacologic treatments) … KQ1b(Non-pharmacologic treatments) KQ2b(Non-pharmacologic
For prevention of DPN Complications treatments … [tiab] OR therapies[tiab]) AND (moving[tiab] OR
sports[tiab])))
OR “Stair Navigation”[tiab] OR postural … therapy”[tiab] OR “cognitive Psychotherapy”[tiab]
OR “behavioral therapy”[tiab] OR “behavioral therapies … Xylocaine (Lidocaine) AstraZeneca
Qutenza (Capsaicin) Acorda Therapeutics, Inc
20
!
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/eRqpfdB7_5FGAFdTEMfwHh
March 15, 2021 - Screening and Treatment for Gestational Diabetes Mellitus
Screening for gestational diabetes usually … For those diagnosed with gestational diabetes, treatment consists of lifestyle changes including physical … Potential Benefits and Harms of Screening and Treatment for Gestational Diabetes Mellitus
The Task … Facts About Gestational Diabetes Mellitus
Screening and Treatment for Gestational Diabetes Mellitus … Potential Benefits and Harms of Screening and Treatment for Gestational Diabetes Mellitus
The Draft
-
meps.ahrq.gov/data_files/publications/rf30/rf30.shtml
September 15, 2010 - (a biguanide) as first-line therapy in treating patients with type 2 diabetes. … The choice of diabetes therapy may depend on many factors such as biochemical assessment of the patient … For individuals with type 1 diabetes (5–10 percent of diagnosed diabetes) insulin is the primary therapy … in 1995 and are currently recommended as first-line therapy for the treatment of type 2 diabetes when … treatment with biguanides as first-line therapy.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/diabetes-1.pdf
March 01, 2020 - Intensive insulin therapy in critically ill patients. … Shift in responsibilities in diabetes care: the Nurse-
Driven Diabetes In-Hospital Treatment protocol … Diabetes management
with a paper-based
protocol for an algorithm-
driven basal-bolus insulin
therapy … insulin
therapy. … treatment, and
standardize
hypoglycemic
management.
-
meps.ahrq.gov/data_files/publications/rf30/rf30.pdf
September 15, 2010 - (a biguanide) as first-line therapy in
treating patients with type 2 diabetes. … For individuals
with type 1 diabetes (5–10 percent of diagnosed diabetes) insulin is the primary therapy … in
1995 and are currently recommended as first-line therapy for the treatment of type 2 diabetes
when … treatment with biguanides as first-line therapy. … adjustment of therapy: a consensus statement of the American Diabetes Association and the
European
-
digital.ahrq.gov/ahrq-funded-projects/monitoring-intensification-treatment-hyperglycemia-and-hyperlipidemia/final-report
January 01, 2023 - Monitoring Intensification of Treatment for Hyperglycemia and Hyperlipidemia in Patients with Diabetes … Monitoring Intensification of Treatment for Hyperglycemia and Hyperlipidemia in Patients with Diabetes … PDF
Monitoring Intensification of Treatment for Hyperglycemia and Hyperlipidemia in Patients … with Diabetes - Final Report
The findings and conclusions in this document are those of the … Principal Investigator
Turchin, Alexander
Project Name
Monitoring Intensification of Treatment